Pathfinder Pharmaceuticals

Ownership

Private

Therapeutic Areas

Oncology

Stage

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Modalities

Small molecules

Pathfinder Pharmaceuticals General Information

Pathfinder Pharmaceuticals is engaged in the earliest stages of drug discovery and development, focusing on inhibition of metabolic pathways used by cancer cells.

Contact Information

Website

http://www.pathfinderpharma.com/

Primary Industry

Biotech

Corporate Office

Durham, North Carolina
United States

Drug Pipeline

No pipeline data available

For full access to Pathfinder Pharmaceuticals's pipeline data

Book a demo

Key Partnerships

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Pathfinder Pharmaceuticals Funding

No funding data available

Early Stage VC (Series A)	04-Jun-2020	$38M	Completed	Phase 1
Seed Round	12-Feb-2019	$8.5M	Completed	Startup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more

To view Pathfinder Pharmaceuticals's complete valuation and funding history, request access »